Plain-English translation of NCT07178808 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a two-part treatment approach for stomach cancer that has spread to the abdominal lining. You would first receive standard chemotherapy, then undergo surgery to remove the cancer, followed by hyperthermic intraperitoneal chemotherapy — a special technique where heated chemotherapy is delivered directly into your abdomen during surgery. The goal is to treat cancer that may be too small to see on imaging or that has spread across the abdominal lining.
Stomach cancer that spreads to the lining of the abdomen is very difficult to treat with standard approaches alone. This trial is testing whether combining surgery with heated chemotherapy delivered directly to the affected area can help patients live longer and have better outcomes.
You likely qualify if…
You likely don't qualify if…
You would receive several rounds of chemotherapy before surgery, then undergo the main surgical procedure where your surgeon removes affected tissue and delivers heated chemotherapy directly into your abdomen. You would need to attend multiple visits for treatment, imaging, and blood work, and you would be followed closely afterward to monitor your recovery and how well the treatment is working. The entire process spans several months from start to finish.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States